Yeji Lee

发表

Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer

Y. Cho, T. Roberts, Seung-Yoon Park, 2021, Journal for ImmunoTherapy of Cancer.

Oral Cancer Immunotherapy through a Simvastatin‐Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity

Y. Byun, In‐San Kim, Gi-Hoon Nam, 2021, Advanced Therapeutics.

In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

Seokjoong Kim, Jun Chang, Hyukjin Lee, 2022, Science advances.

Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer

A. Khademhosseini, M. Dokmeci, Junmin Lee, 2023, Bioactive materials.

Micromechanical property mismatch between pericellular and extracellular matrices regulates stem cell articular and hypertrophic chondrogenesis

S. Ahadian, A. Khademhosseini, M. Dokmeci, 2022, Matter.

In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector.

Seokjoong Kim, Hyukjin Lee, D. Song, 2023, Molecular therapy. Nucleic acids.

Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.

Hyukjin Lee, M. Jeong, Jeongeun Park, 2023, Advanced drug delivery reviews.

Novel piperazine‐based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety

Hyukjin Lee, MinJeong Kim, M. Jeong, 2023, Bioengineering & Translational Medicine.

Fugetaxis of Cell-in-Catalytic-Coat Nanobiohybrids in Glucose Gradients.

I. Choi, Hyun-Sook Choi, Hojae Lee, 2023, Small.